Pre- and Postoperative State of Coagulation and Fibrinolysis in Plasma of Patients with Benign and Malignant Colorectal Disease - A Preliminary Study

 

PDF Download Buy Article Permissions and Reprints

Summary

This study was carried out in order to compare the coagulation balance in patients with colorectal cancer before and after surgical removal of tumor with an age matched non-malignancy control group. Furthermore, it was studied whether preoperative coagulation state in cancer patients was correlated to the postoperative development of deep venous thrombosis (DVT) diagnosed by venography. Plasma was collected preoperatively in 93 cancer patients and 30 controls, and postoperatively on day one, two, seven, and ninety in 88 cancer patients and 18 controls. Prothrombin fragment 1 + 2 (F1 + 2), thrombin-antithrombin complex (TAT), and total fibrin(ogen) degradation products (TDP) were quantitated in plasma by enzyme linked immunosorbent assays (ELISA). As compared to controls, patients admitted for cancer treatment displayed significantly higher levels of F1 + 2 and TAT. Patients suffering from advanced colorectal cancer had significantly higher levels of TAT and TDP as compared to patients with localized colorectal cancer. Twenty-three percent of cancer patients developed DVT postoperatively. Preoperatively these patients displayed significantly higher TDP levels, and postoperatively higher levels of F1 + 2, TAT, and TDP compared to cancer patients without DVT. The marked activation of blood coagulation and fibrinolysis observed in all patients following major abdominal surgery was even more pronounced in patients not cured for cancer.

• References

• 1 Edwards RL, Rickies FR, Moritz TE, Henderson WG, Zacharski LR, Forman WB, Cornell CJ, Fortier RJ, O’Donnell JF, Headley E. et al Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987; 88: 596-602
  CrossrefPubMedGoogle Scholar
• 2 Rickies FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11: 237-248
  CrossrefPubMedGoogle Scholar
• 3 Rahr HB, Sprensen JV. Venous thromboembolism and cancer. Blood Coagul Fibrinolysis 1992; 3: 451-460
  CrossrefPubMedGoogle Scholar
• 4 Bounameaux H, Huber O, Khabiri E, Schneider PA, Didier D, Rohner A. Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low-molecular-weight heparin. Arch Surg 1993; 128: 326-328
  CrossrefPubMedGoogle Scholar
• 5 Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallbook T, Hedberg M, Horn A, Kelty E, Kvitting P, Lindhagen A. et al Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients. Br J Surg 1995; 82: 496-501
  CrossrefPubMedGoogle Scholar
• 6 Wiig JN, Solhaug JH, Bilberg T, Bjerkeset T, Edwin B, Griiner OP, Havig Y, Holter O, Knudsen G, Lundblad R. et al Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicenter trials 20 mg and 40 mg Enoxaparin versus dextran. Eur J Surg 1995; 161: 663-668
  PubMedGoogle Scholar
• 7 Falanga A, Barbui T, Rickies FR, Levine MN. Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis. Thromb Haemost 1993; 70: 540-542
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Iversen LH, Thorlacius-Ussing O, Okholm M. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease. Thromb Res 1995; 79: 471-481
  CrossrefPubMedGoogle Scholar
• 9 Falanga A, Ofosu FA, Cortelazzo S, Delaini F, Consonni R, Caccia R, Longatti S, Maran D, Rodeghiero F, Pogliani E. et al Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Br J Haematol 1993; 85: 745-750
  CrossrefPubMedGoogle Scholar
• 10 Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-144
  CrossrefPubMedGoogle Scholar
• 11 Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-159
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrom-bin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-106
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Koopman J, Haverkate F, Koppert P, Nieuwenhuizen W, Brommer EJ, Van der Werf WG. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 1987; 109: 75-84
  PubMedGoogle Scholar
• 14 Armitage P, Berry G. In: Statistical methods in medical research. Second ed Blackwell Scientific Publications; London: 1987
• 15 Miettinen OS. Simple interval-estimation of risk ratio. [Abstract] Am J Epidemiol 1974; 100: 515-516
  PubMedGoogle Scholar
• 16 Zacharski LR, Wojtukiewicz MZ, Costantini V, Omstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992; 18: 104-116
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 van Duijnhoven EM, Lustermans FA, van Wersch JW. Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer. Haemostasis 1993; 23: 168-172
  PubMedGoogle Scholar
• 18 Edwards CM, Warren J, Armstrong L, Donnelly PK. D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg 1993; 80: 1404-1405
  CrossrefPubMedGoogle Scholar
• 19 McCulloch P, Nieuwenhuizen W, Douglas J, Lowe GD, George WD. Coagulation disturbances in cancer of the breast and colon measured with specific monoclonal antibody enzyme immunoassay for fibrin-fibrinogen degradation products. Haemostasis 1990; 20: 73-80
  PubMedGoogle Scholar
• 20 Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 1987; 80: 1527-1534
  CrossrefPubMedGoogle Scholar
• 21 Cadroy Y, Pierrejean D, Fontan B, Sié P, Boneu B. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hematol 1992; 34: 43-46
  PubMedGoogle Scholar
• 22 Hursting MJ, Stead AG, Crout FV, Horvath BZ, Moore BM. Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. Clin Chem 1993; 39: 683-686
  PubMedGoogle Scholar
• 23 Lindahl AK, Boffa MC, Abildgaard U. Increased plasma thrombomodulin in cancer patients. Thromb Haemost 1993; 69: 112-114
  Article in Thieme ConnectPubMedGoogle Scholar
• 24 van Wersch JW, Peters C, Ubachs HM. Haemiostasis activation markers in plasma of patients with benign and malignant gynaecological tumours: a pilot study. Eur J Clin Chem Clin Biochem 1995; 33: 225-229
  PubMedGoogle Scholar
• 25 Torngren S, Rieger A. Prophylaxis of deep venous thrombosis in colorectal surgery. Dis Colon Rectum 1982; 25: 563-566
  CrossrefPubMedGoogle Scholar
• 26 Wille JprgensenP, Ott P. Predicting failure of low-dose prophylactic heparin in general surgical procedures. Surg Gynecol Obstet 1990; 171: 126-130
  PubMedGoogle Scholar
• 27 Wille JprgensenP, Thorup J, Fischer A, Holst ChristensenHJ, Flamsholt R. Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: a randomized trial. Br J Surg 1985; 72: 579-581
  CrossrefPubMedGoogle Scholar
• 28 Pratt CW, Church FC. Antithrombin: structure and function. Semin Hematol 1991; 28: 3-9
  PubMedGoogle Scholar
• 29 Bauer KA, Goodman TL, Kass BL, Rosenberg RD. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest 1985; 76: 826-836
  CrossrefPubMedGoogle Scholar